FibroGen, Inc.
FGEN
$0.2912
-$0.0269-8.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -93.23% | -8.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -93.23% | -8.51% | |||
| Cost of Revenue | -96.20% | -31.26% | |||
| Gross Profit | -89.08% | 70.20% | |||
| SG&A Expenses | -52.46% | -21.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -78.97% | -27.62% | |||
| Operating Income | -451.01% | 116.27% | |||
| Income Before Tax | 49.26% | -8.01% | |||
| Income Tax Expenses | -83.33% | 104.58% | |||
| Earnings from Continuing Operations | 49.28% | -9.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 205.26% | -9.91% | |||
| EBIT | -451.01% | 116.27% | |||
| EBITDA | -333.88% | 124.81% | |||
| EPS Basic | 204.88% | -9.18% | |||
| Normalized Basic EPS | -622.83% | 109.29% | |||
| EPS Diluted | 204.88% | -9.18% | |||
| Normalized Diluted EPS | -622.83% | 109.29% | |||
| Average Basic Shares Outstanding | 0.31% | 0.68% | |||
| Average Diluted Shares Outstanding | 0.31% | 0.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||